Evidera
Nicola Barnes is a seasoned professional in health economics and outcomes research, currently serving as a Senior Research Scientist at Evidera since January 2020. Previously, at Creativ-Ceutical from August 2016 to January 2020, Nicola managed various HEOR projects, focusing on Patient-Reported Outcomes (PRO) instrument development and qualitative research, while also teaching a course on PRO strategies. Prior experience includes senior roles at GIM France and Mapi Consultancy, leading marketing research projects in the pharmaceutical sector and contributing to qualitative PRO projects throughout the drug product life-cycle. Nicola began the career as an English teacher at Université Lyon 2 and INSA Lyon. Educational qualifications include a BA/MA in French and German from the University of Cambridge and postgraduate research at the Ecole normale supérieure de Lettres et Sciences humaines.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.